Abstract
Polycythemia vera (PV) is one of the three main classic disorders of Philadelphia-negative myeloproliferative neoplasms (MPNs), with the other two being essential thrombocythemia (ET) and primary myelofibrosis (PMF). PV may develop (15%) in women of childbearing age (15–45 years), with an anticipated rate of roughly 0.3 per 100,000 people, although maintaining a male to female ratio predominance of about 2:1 and a peak prevalence in the sixth and seventh decades of life. Without always being presented with its actual clinical manifestations due to pregnancy itself, and most commonly due to iron deficiency, PV can be frequently missed and therefore belatedly diagnosed. We describe the case of a primipara woman in her 40s, without risk factors for thrombosis, who developed a portal vein occlusion 1.5 month postpartum after C-section and who had a delayed diagnosis of PV.
Reference13 articles.
1. Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study;Alimam;Br. J. Haemotol.,2016
2. Pillai, A.A., and Babiker, H.M. (2022, September 19). Polycythemia, Available online: https://www.ncbi.nlm.nih.gov/books/NBK526081/.
3. A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis;Mead;Br. J. Haematol.,2019
4. Polycythemia vera in pregnancy represents a challenge for a multidisciplinary collaboration: A case report and literature review;Bohiltea;Exp. Ther. Med.,2022
5. Aaron, T., and Gerds, M.D. (2022, October 07). Myeloproliferative Neoplasms. Cleveland Clinic, Center for Continuing Education. Available online: http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/hematology-oncology/chronic-myeloproliferative-disorders/.